HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Edward R T Tiekink Selected Research

Bismuth

1/2014A bismuth diethyldithiocarbamate compound promotes apoptosis in HepG2 carcinoma, cell cycle arrest and inhibits cell invasion through modulation of the NF-κB activation pathway.
5/2007Cytotoxicity, qualitative structure-activity relationship (QSAR), and anti-tumor activity of bismuth dithiocarbamate complexes.
6/2002Antimony and bismuth compounds in oncology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Edward R T Tiekink Research Topics

Disease

10Neoplasms (Cancer)
04/2023 - 06/2002
4Rheumatoid Arthritis
06/2018 - 06/2002
3Necrosis
03/2024 - 09/2013
3Breast Neoplasms (Breast Cancer)
01/2017 - 09/2013
3Bites and Stings (Sting)
07/2012 - 08/2010
2Carcinoma (Carcinomatosis)
01/2014 - 12/2008
1Leukemia
03/2024
1Colorectal Neoplasms (Colorectal Cancer)
03/2024
1Infections
11/2023
1Triple Negative Breast Neoplasms
07/2020
1Neuroblastoma
02/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
02/2019
1Urinary Bladder Neoplasms (Bladder Cancer)
02/2019
1Glioblastoma (Glioblastoma Multiforme)
02/2019
1Noncommunicable Diseases
04/2017
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2017
1Neuralgia (Stump Neuralgia)
08/2010
1Hyperalgesia
08/2010
1Leishmaniasis
06/2002
1Ulcer
06/2002

Drug/Important Bio-Agent (IBA)

5Cisplatin (Platino)FDA LinkGeneric
04/2023 - 12/2008
3Gold CompoundsIBA
06/2018 - 01/2003
3BismuthIBA
01/2014 - 06/2002
3LigandsIBA
07/2012 - 08/2010
2Schiff Bases (Schiff Base)IBA
02/2019 - 05/2015
2Reactive Oxygen Species (Oxygen Radicals)IBA
02/2019 - 09/2013
2MetalsIBA
06/2018 - 06/2002
2GoldIBA
06/2018 - 06/2002
2CaspasesIBA
01/2014 - 09/2013
1Chimeric Antigen ReceptorsIBA
03/2024
1DNA (Deoxyribonucleic Acid)IBA
03/2024
1Intercalating AgentsIBA
03/2024
1PyridinesIBA
03/2024
1Anti-Bacterial Agents (Antibiotics)IBA
11/2023
1Antineoplastic Agents (Antineoplastics)IBA
07/2020
1diphenyltinIBA
02/2019
1PlatinumIBA
06/2018
1Anti-Infective Agents (Microbicides)IBA
04/2017
1Benzoates (Benzoate)IBA
01/2017
1Mitogen-Activated Protein KinasesIBA
01/2017
1triphenyltin (triphenyltin hydride)IBA
01/2017
1JNK Mitogen-Activated Protein KinasesIBA
01/2017
1Estrogen ReceptorsIBA
05/2015
1Coordination ComplexesIBA
05/2015
1Ditiocarb (Sodium Diethyldithiocarbamate)FDA Link
01/2014
1phosphine (phosphane)IBA
09/2013
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2013
1Type I DNA Topoisomerases (Topoisomerase I)IBA
09/2013
1Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
04/2011
1Type II DNA Topoisomerases (Topoisomerase II)IBA
04/2011
1Thymidylate SynthaseIBA
04/2011
1Phosphorylases (Glucan Phosphorylase)IBA
04/2011
1EnzymesIBA
04/2011
1Glutamate Receptors (Glutamate Receptor)IBA
08/2010
1Amino AcidsFDA Link
08/2010
1Paclitaxel (Taxol)FDA LinkGeneric
05/2007
1Auranofin (Ridaura)FDA Link
01/2003
1AntimonyIBA
06/2002

Therapy/Procedure

3Therapeutics
03/2024 - 01/2017
1Immunotherapy
03/2024
1Aftercare (After-Treatment)
03/2024
1Drug Therapy (Chemotherapy)
03/2024